Endometriosis and Glanzmann’s thrombasthenia

J Biol Regul Homeost Agents. 2016 Jul-Sep;30(3):877-882.

Abstract

Glanzmann’s thrombasthenia (GT) is a rare bleeding syndrome characterized by deficiency or defect of platelet aggregation complex. The pathogenesis of endometriosis is controversial but the strongest evidence leans towards retrograde menstruation. GT probably predisposes to endometriosis. The management of women affected by this disease can be difficult due to the risk of bleeding complications, especially during surgical treatment. We describe the cases of three sisters affected by endometriosis and GT, referred to our Department, who received different therapeutic management.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Contraceptives, Oral, Hormonal / adverse effects
  • Contraceptives, Oral, Hormonal / therapeutic use
  • Disease Susceptibility
  • Diseases in Twins
  • Endometriosis / diagnostic imaging
  • Endometriosis / drug therapy
  • Endometriosis / etiology*
  • Endometriosis / surgery
  • Factor VIIa / therapeutic use
  • Female
  • Hematometra / etiology
  • Hemorrhagic Disorders / drug therapy
  • Hemorrhagic Disorders / etiology
  • Humans
  • Intrauterine Devices, Medicated
  • Levonorgestrel / therapeutic use
  • Medroxyprogesterone Acetate / therapeutic use
  • Menorrhagia / etiology
  • Ovarian Diseases / diagnostic imaging
  • Ovarian Diseases / drug therapy
  • Ovarian Diseases / etiology
  • Ovarian Diseases / surgery
  • Perioperative Care
  • Recombinant Proteins / therapeutic use
  • Rectal Diseases / diagnostic imaging
  • Rectal Diseases / drug therapy
  • Rectal Diseases / etiology
  • Thrombasthenia / complications*
  • Thrombasthenia / genetics
  • Tranexamic Acid / therapeutic use
  • Triptorelin Pamoate / therapeutic use
  • Vaginal Diseases / diagnostic imaging
  • Vaginal Diseases / drug therapy
  • Vaginal Diseases / etiology

Substances

  • Contraceptives, Oral, Hormonal
  • Recombinant Proteins
  • Triptorelin Pamoate
  • Levonorgestrel
  • Tranexamic Acid
  • recombinant FVIIa
  • Medroxyprogesterone Acetate
  • Factor VIIa